Lineage Cell Therapeutics Inc (LCTX)

[Cincinnatus]

Of course this is all speculation. You say " to attract investors to fund the development and form good investor base before the spinoff." How about via an IPO or other arrangement connected to the spinoff?

Assuming the distribution date will be set soon (before mid-June), and we know nothing for sure how that's going to be structured...it still is a fact that they are going to need to raise some funds to start implementing their plans for their 3 focused objectives in the Summary slide. Very bluntly, the 510(K) route which could reach APPROVAL in as little as 6 months would draw more funds more quickly than the other two objectives which would have to take many years to gain approval. That is why I'm hoping slide 9 is their opening salvo for more specific information to come coinciding with the time period around the distribution date.

One last time...we're just not communicating well around the 510(K) process. This is a device request. There is no P1, P2, or P3 required. The drug involved has already gone through that drawn out FDA process and gained approval. 510(K) Approval means APPROVAL...go sell it. I'm guessing the 510(K) application will aim at one or two specific markets...Cox mentions scarless healing in cosmetic skin or hair rejuvenation, heart disease, or blindness as possibilities (that's quite a range of markets!) If they achieve success with the first market, they can go back with new 510(K) applications and expand scarless healing into myriad markets.

They freed AST and OCX when they had something going that was already proceeding through the clinic toward well defined goals. Why spinoff AgeX if everything they're focused on has no revenue possibilities for 6-10 years? Wouldn't make sense and would be very difficult to engender money raising enthusiasm.